EverQuote (NASDAQ:EVER – Get Rating) had its price target lowered by Oppenheimer from $20.00 to $15.00 in a research note issued to investors on Tuesday, The Fly reports. Oppenheimer’s price target would indicate a potential upside of 1.49% from the company’s previous close.
Other analysts also recently issued reports about the company. William Blair downgraded EverQuote from an “outperform” rating to a “market perform” rating in a research note on Tuesday. Raymond James cut EverQuote from an “outperform” rating to a “market perform” rating in a research note on Tuesday. B. Riley began coverage on shares of EverQuote in a research report on Monday, April 18th. They issued a “buy” rating and a $20.00 price objective on the stock. Finally, Needham & Company LLC upped their price objective on shares of EverQuote from $17.00 to $19.00 and gave the stock a “buy” rating in a research report on Thursday, February 17th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $21.75.
Shares of EVER opened at $14.78 on Tuesday. The company’s 50 day simple moving average is $14.73 and its 200-day simple moving average is $15.03. The firm has a market cap of $437.19 million, a PE ratio of -22.06 and a beta of 1.18. EverQuote has a 12-month low of $11.73 and a 12-month high of $35.79.
In other news, CFO John Brandon Wagner sold 3,600 shares of EverQuote stock in a transaction that occurred on Monday, February 7th. The shares were sold at an average price of $17.00, for a total transaction of $61,200.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Tomas Revesz, Jr. sold 7,119 shares of EverQuote stock in a transaction that occurred on Tuesday, March 29th. The shares were sold at an average price of $15.29, for a total transaction of $108,849.51. Following the sale, the insider now owns 460,409 shares of the company’s stock, valued at $7,039,653.61. The disclosure for this sale can be found here. In the last 90 days, insiders sold 12,734 shares of company stock valued at $201,279. 37.22% of the stock is owned by insiders.
Several hedge funds have recently bought and sold shares of EVER. Rubric Capital Management LP acquired a new stake in shares of EverQuote during the 4th quarter valued at approximately $20,019,000. BlackRock Inc. raised its position in shares of EverQuote by 26.2% during the 3rd quarter. BlackRock Inc. now owns 1,601,354 shares of the company’s stock worth $29,833,000 after purchasing an additional 332,492 shares during the last quarter. Granahan Investment Management Inc. MA raised its position in shares of EverQuote by 38.0% during the 3rd quarter. Granahan Investment Management Inc. MA now owns 1,131,777 shares of the company’s stock worth $21,085,000 after purchasing an additional 311,561 shares during the last quarter. Two Sigma Investments LP raised its position in shares of EverQuote by 449.5% during the 3rd quarter. Two Sigma Investments LP now owns 335,170 shares of the company’s stock worth $6,244,000 after purchasing an additional 274,176 shares during the last quarter. Finally, Marshall Wace LLP acquired a new position in shares of EverQuote during the 3rd quarter worth approximately $4,990,000.
About EverQuote (Get Rating)
EverQuote, Inc operates an online marketplace for insurance shopping in the United States. The company's online marketplace offers consumers shopping for auto, home and renters, life, and health insurance. It serves carriers and agents, as well as indirect distributors. The company was formerly known as AdHarmonics, Inc, and changed its name to EverQuote, Inc in November 2014.
Read More
- Get a free copy of the StockNews.com research report on EverQuote (EVER)
- MarketBeat Podcast: Investing In Innovation, Robotics, AI and Healthcare
- It’s Time to Book an Appointment for Teladoc Stock
- GitLab Stock is Trying to Put in a Bottom Here
- Saia Growth Accelerates But It May Not Matter
- onsemi Is A Deep-Value In The Chip Sector
Receive News & Ratings for EverQuote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EverQuote and related companies with MarketBeat.com's FREE daily email newsletter.